Welcome to LookChem.com Sign In|Join Free
  • or
benzyl 5-(methanesulfonyl)pentanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1346933-07-0

Post Buying Request

1346933-07-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1346933-07-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1346933-07-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,9,3 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1346933-07:
(9*1)+(8*3)+(7*4)+(6*6)+(5*9)+(4*3)+(3*3)+(2*0)+(1*7)=170
170 % 10 = 0
So 1346933-07-0 is a valid CAS Registry Number.

1346933-07-0Relevant academic research and scientific papers

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

-

, (2016/02/22)

The present invention provides novel, stable lipid particles having a non-lamellar structure and comprising one or more active agents or therapeutic agents, methods of making such lipid particles, and methods of delivering and/or administering such lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) that have a non-lamellar structure and that comprise a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.

COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B

-

, (2013/05/22)

The present invention provides compositions and methods for the delivery of interfering RNAs such as siRNAs that silence APOB expression in cells such as liver cells. In particular, the nucleic acid-lipid particles provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells such as liver cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of APOB at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

-

, (2011/12/02)

The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1346933-07-0